KNC Laboratories Co.,Ltd. (6568.T) Financial Statements

Income statement

Metric	TTM	2026	2025	2024	2023
Revenue
Total Revenue	8.5B	9.1B	8.2B	9.2B	8.6B
Cost of Revenue	1.3B	6.7B	5.9B	5.9B	5.3B
Gross Profit	369.6M	2.4B	2.3B	3.3B	3.3B
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	378.9M	1.4B	1.5B	1.2B	1.1B
General & Admin Expense	—	—	—	—	—
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	—	—	—	—	—
Total Operating Expenses	378.9M	1.4B	1.5B	1.2B	1.1B
Cost and Expenses	7.9B	8.1B	7.4B	7.1B	6.5B
Operating Income (EBIT)	603.0M	1.0B	771.0M	2.1B	2.2B
Non-Operating
Interest Income	—	3.7M	1.2M	18.0K	14.0K
Interest Expense	7.7M	34.5M	19.2M	9.4M	9.7M
Net Interest Income	—	(30.8M)	(18.0M)	(9.3M)	(9.7M)
Other Non-Op Income/Expense	(2.3M)	4.2M	157.7M	13.4M	35.4M
Non-Operating Income (excl Interest)	1.8M	35.3M	175.9M	23.3M	45.3M
EBT (Pre-Tax Income)	(11.6M)	1.0B	928.0M	2.1B	2.2B
Income Tax Expense	(288.0K)	259.6M	190.7M	600.2M	629.5M
Bottom Line
Net Income	504.0M	766.0M	737.0M	1.5B	1.5B
Earnings from Cont. Ops	—	—	—	—	—
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	504.0M	766.0M	737.0M	1.5B	1.5B
Per Share
Basic EPS	¥65	¥99	¥95	¥194	¥200
Diluted EPS	¥65	¥99	—	—	—
Revenue Per Share	¥1,101	¥1,175	¥1,058	¥1,186	¥1,119
Shares
Basic Shares Outstanding	7.7M	7.7M	7.7M	7.7M	7.7M
Diluted Shares Outstanding	—	—	—	—	—
Profitability Metrics
EBITDA	—	2.3B	1.7B	3.0B	3.1B
D&A	—	1.2B	879.3M	922.4M	919.1M
EBIT	603.0M	1.0B	771.0M	2.1B	2.2B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026